Mechanism of Action and Initial, In Vitro SAR of an Inhibitor of the Shigella flexneri Virulence Regulator VirF

PloS One
Anthony A Emanuele, George A Garcia

Abstract

Shigella spp. are among the main causative agents of acute diarrheal illness and claim more than 1 million lives per year worldwide. There are multiple bacterial genes that control the pathogenesis of Shigella, but the virF gene may be the most important. This gene, located on the primary pathogenicity island of Shigella, encodes VirF, an AraC-family transcriptional activator that is responsible for initiating the pathogenesis cycle in Shigella. We have previously shown that it is possible to attenuate the virulence of Shigella flexneri via small molecule inhibition of VirF. In this study, we probed the mechanism of action of our small molecule inhibitors of VirF. To enable these studies, we have developed a homologous and efficient expression and purification system for VirF and have optimized two different in vitro VirF-DNA binding assays. We have determined that one of our HTS hit compounds inhibits VirF binding to DNA with a calculated Ki similar to the effective doses seen in our transcriptional activation and virulence screens. This is consistent with inhibition of DNA binding as the mechanism of action of this hit compound. We have also screened 15 commercially sourced analogs of this compound and deduced an initial SAR ...Continue Reading

References

May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M L BernardiniP J Sansonetti
Feb 12, 1998·Molecular & General Genetics : MGG·M E Porter, C J Dorman
Nov 26, 1998·The Journal of Biological Chemistry·H HilbiA Zychlinsky
Apr 3, 2001·Current Opinion in Microbiology·R G Martin, J L Rosner
Feb 22, 2003·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·Robert Schleif
Jan 21, 2004·Accounts of Chemical Research·Winston C Tse, Dale L Boger
Jan 30, 2004·Biophysical Journal·Binh NguyenW David Wilson
Jul 25, 2006·Infection and Immunity·Marianela EspinaWendy L Picking
Sep 4, 2007·Bioorganic & Medicinal Chemistry Letters·Todd E BowserMichael N Alekshun
Apr 23, 2008·Current Protocols in Nucleic Acid Chemistry·Winston C Tse, Dale L Boger
Aug 28, 2009·Journal of Medicinal Chemistry·Oak K KimMichael N Alekshun
Mar 20, 2010·Journal of Biomolecular Screening·Julie K HurtGeorge A Garcia
May 19, 2011·Journal of Visualized Experiments : JoVE·Cila Herman, Muge Pirtini Cetingul
Oct 13, 2011·BioTechniques·Nicolas Jullien, Jean-Paul Herman
Feb 1, 2013·Journal of Biomolecular Screening·Jeff M SkredenskeSusan M Egan
Sep 5, 2013·Infection and Immunity·Veerendra KoppoluSusan M Egan
Apr 12, 2014·Cell Host & Microbe·Anna Brotcke ZumstegArturo Zychlinsky

❮ Previous
Next ❯

Methods Mentioned

BETA
gel filtration
Assay
Fluorescence
Fluorescence Intercalator Displacement

Software Mentioned

GraphPad Prism

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.